...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Accelerated approval
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hey Narmac, as much as I like you and your awesome profile picture, I disagree. The upfront money (close to 10M quickly) with Newsoara is a game changer so is the Pfizer collaboration. 2019 was different from the other years!

I could give you the constant IPO pushback. I would love to buy some Zenith shares!

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply